Bio Techne earnings were $131.7M for the trailing 12 months ending Mar 31, 2025, with -34.6% growth year over year. The latest TECH earnings report on Mar 31, 2025 announced Q1 2025 earnings of $22.6M, down 35.3% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, TECH reported annual earnings of $168.1M, with -41.1% growth.
TECH past earnings growth
How has TECH's earnings growth performed historically?
On TECH's earnings call on Invalid Date, Bio Techne (NASDAQ: TECH) reported Q1 2025 earnings per share (EPS) of $0.14, up 54.84% year over year. Total TECH earnings for the quarter were $22.59 million. In the same quarter last year, Bio Techne's earnings per share (EPS) was $0.31.
As of the last Bio Techne earnings report, Bio Techne is currently profitable. Bio Techne's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $131.67 million, a 35.14% decrease year over year.
What was TECH's earnings growth in the past year?
As of Bio Techne's earnings date in Invalid Date, Bio Techne's earnings has grown -34.65% year over year. This is 46.18 percentage points lower than the US Biotechnology industry earnings growth rate of 11.53%. TECH earnings in the past year totalled $131.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.